Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine · 2002 · 5.6K citations · Full text

Medicine, Immunology, Oncology +9

Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

Thierry Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine · 1995 · 2.4K citations

Medicine, Hematology, Oncology +14

Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

Craig H. Moskowitz, Joseph R. Bertino, Jill R. Glassman et al. · Journal of Clinical Oncology · 1999 · 303 citations

Medicine, Hematology, Oncology +14

The role of rituximab and chemotherapy in aggressive B-cell lymphoma: A preliminary report of dose-adjusted EPOCH-R

Wyndham H. Wilson, Martin Gutierrez, Paula G. O’Connor et al. · Seminars in Oncology · 2002 · 82 citations

Medicine, Oncology, Pharmacotherapy +14